Cardiovascular
What Causes Heart Palpitations in Endometriosis?
Heart palpitations are an under-discussed symptom in endometriosis — yet up to 40% of women with the condition report cardiovascular symptoms that their gynecologist never flagged. The connection runs through estrogen fluctuations, systemic inflammation, magnesium depletion, and autonomic nervous system dysregulation, all of which can fire together in the same person.
What Causes Heart Palpitations in Endometriosis?
Yes, endometriosis can directly cause heart palpitations — and the mechanism is multi-layered. Fluctuating estrogen disrupts cardiac ion channels, chronic pelvic inflammation elevates inflammatory cytokines that affect heart rhythm, and the condition quietly depletes magnesium, a mineral the heart depends on. The exception: if palpitations are frequent, prolonged, or paired with chest pain or syncope, a cardiologist visit is non-negotiable regardless of the hormonal picture.
---
Why Endometriosis Affects the Heart, Not Just the Pelvis
Endometriosis is classified as a systemic inflammatory disease, not purely a reproductive one. Lesions outside the uterus produce prostaglandins and pro-inflammatory cytokines — including IL-6, IL-1β, and TNF-α — that circulate throughout the body (Giudice & Kao, Lancet 2004; PMID: 15541453). These inflammatory mediators affect vascular tone, autonomic balance, and cardiac electrical activity in ways that are only beginning to be appreciated in clinical literature.
A 2022 population-level analysis published in Heart found that women diagnosed with endometriosis carried a meaningfully higher risk of arrhythmia compared to matched controls, an association that persisted even after adjusting for common confounders (Mu et al., Heart 2022; PMID: 35256498). The researchers pointed to shared inflammatory pathways and estrogen signaling as the most likely mechanistic bridges.
This systemic view matters because it explains why palpitations don't always track the menstrual cycle. When inflammation is the driver — not just estrogen peaks — palpitations can appear at any point in the month.
---
The Estrogen–Cardiac Ion Channel Connection
Estrogen is not just a reproductive hormone. Cardiac muscle cells express estrogen receptors (ERα and ERβ), and estrogen directly modulates the ion channels — particularly L-type calcium channels and hERG potassium channels — that govern the heart's electrical cycle (Regitz-Zagrosek & Kararigas, Physiol Rev 2017; PMID: 28123015). When estrogen surges before ovulation or crashes during the luteal phase, these channels can fire irregularly, producing the skipped-beat or fluttering sensation patients describe.
In endometriosis, estrogen levels are not simply "high" or "low" — they oscillate unpredictably due to both endogenous lesion-driven estrogen production and hypothalamic-pituitary-ovarian axis disruption. This irregular signaling environment is more arrhythmogenic than a stable estrogen state in either direction.
If you're already tracking what causes high CRP on your labs, this is a good moment to connect those dots: CRP elevations in endometriosis aren't cosmetic — they reflect the same systemic inflammatory burden that unsettles cardiac rhythm.
---
What Causes Heart Palpitations in Perimenopause?
Perimenopause — the 4–10 year hormonal transition before the final menstrual period — layers additional complexity onto any pre-existing endometriosis-related palpitations. During this window, estradiol levels can swing more dramatically month to month than at any other reproductive life stage.
A cross-sectional study of 1,000 midlife women found that 54% reported palpitations during perimenopause, making it one of the three most common vasomotor symptoms alongside hot flashes and sleep disruption (Gold et al., Menopause 2000; PMID: 10957804). The mechanism is the same cardiac ion channel disruption described above, but now compounded by rising FSH (which has its own cardiac effects) and declining progesterone, which normally has a calming, GABA-like influence on the autonomic nervous system.
For women who had endometriosis for years before perimenopause, this phase often feels like a sudden escalation — when in reality, the biological scaffolding for palpitations was built earlier and perimenopause simply lowers the threshold.
Understanding what causes HDL to be out of range is also relevant here: perimenopause commonly suppresses HDL, and low HDL has been independently associated with increased cardiac event risk in women with inflammatory conditions.
---
What Causes Heart Palpitations in Menopause and Postmenopause?
In established menopause (12+ consecutive months without a period) and postmenopause, palpitations are often attributed purely to estrogen withdrawal — but the picture is more nuanced. Once estrogen stabilizes at its new (lower) baseline, cardiac ion channels adapt. For many women, palpitations diminish. But for those with ongoing inflammatory load — including unresolved or surgically treated endometriosis — palpitations can persist independently of ovarian function.
Postmenopausal women with a history of endometriosis also show elevated cardiovascular risk markers, including higher homocysteine and worse lipid profiles, compared to postmenopausal women without the condition (Mu et al., Heart 2022; PMID: 35256498). Elevated homocysteine is itself a cardiac irritant; it damages the vascular endothelium and has been associated with arrhythmia risk in mechanistic studies. If you want to understand this marker more deeply, what causes homocysteine to be out of range is worth reading alongside this article.
Magnesium deficiency — common in postmenopausal women due to reduced dietary absorption and estrogen's role in intestinal magnesium uptake — is another underappreciated driver. Magnesium stabilizes cardiac membranes by antagonizing calcium influx; without adequate magnesium, the threshold for ectopic beats drops significantly.
---
What Causes Heart Palpitations After a Hysterectomy?
Hysterectomy — particularly bilateral salpingo-oophorectomy (BSO), where the ovaries are removed — induces surgical menopause, and the abruptness of this hormonal shift is far more arrhythmogenic than natural menopause. Estrogen drops from reproductive levels to near-zero within days rather than years.
Studies on surgical menopause show a higher incidence of palpitations, vasomotor symptoms, and autonomic dysregulation compared to natural menopause, especially in the first 12 months post-surgery (Rocca et al., Menopause 2008; PMID: 18174881). The autonomic nervous system — which governs heart rate variability — is heavily regulated by estrogen, and sudden withdrawal shifts the balance toward sympathetic dominance: faster resting heart rate, lower heart rate variability, and greater susceptibility to ectopic beats.
For women who had endometriosis prior to hysterectomy, systemic inflammatory burden may not fully resolve even after surgical removal of visible lesions, leaving the cardiac environment primed for palpitations even without ovarian hormones in the picture.
This is also why triglyceride management matters post-hysterectomy: abrupt estrogen loss disrupts hepatic lipid metabolism, and elevated triglycerides compound cardiovascular risk. What causes triglycerides to be out of range provides a functional-medicine framework for interpreting these changes.
---
The Magnesium–Autonomic Nervous System–Palpitation Triangle
Across all of these scenarios — endometriosis, perimenopause, menopause, postmenopause, and post-hysterectomy — one nutritional thread appears repeatedly: magnesium depletion.
Estrogen promotes cellular magnesium uptake. As estrogen declines (or fluctuates), magnesium can shift out of cells and into urine, reducing total body magnesium even when serum levels appear normal. A 2018 systematic review found that hypomagnesemia was significantly associated with cardiac arrhythmias including supraventricular ectopy, and that repletion reduced arrhythmia frequency in deficient subjects (Gröber et al., Nutrients 2018; PMID: 29387044).
Magnesium also modulates the parasympathetic-sympathetic balance. Low magnesium → higher sympathetic tone → lower heart rate variability → more palpitations. This triangulated pathway explains why some women with structurally normal hearts and normal thyroid panels still report near-daily palpitations — a magnesium status check (ideally RBC magnesium, not serum) often reveals the gap.
---
Inflammatory Biomarkers Worth Tracking
If you experience palpitations in the context of endometriosis or hormonal transition, these are the lab markers most likely to provide actionable information:
| Marker | What It Reflects | Functional Target |
|---|---|---|
| hsCRP | Systemic inflammatory burden | <1.0 mg/L |
| Homocysteine | Vascular and cardiac irritation | <7 μmol/L |
| RBC Magnesium | True intracellular magnesium status | 5.2–6.4 mg/dL |
| Fasting insulin | Insulin resistance → sympathetic drive | <5 μIU/mL |
| ApoB | Atherogenic lipid particle load | <80 mg/dL |
| TSH + Free T3 | Thyroid — major cardiac rhythm regulator | TSH 1.0–2.0 mIU/L |
Thyroid dysregulation deserves a special mention: hypothyroidism and hyperthyroidism both cause palpitations, and endometriosis is associated with higher rates of autoimmune thyroid disease. A normal TSH does not rule out subclinical thyroid dysfunction as a co-contributor.
---
What This Means for Your Formula
Addressing hormone-driven and inflammation-driven palpitations requires a targeted, evidence-based approach rather than a generic women's multi. Here is how Ones approaches this specifically:
Magnesium Glycinate — dosed within the clinical range studied for cardiac and autonomic benefit (~300–400 mg elemental magnesium per day), this form has superior bioavailability and less laxative effect than oxide. Ones uses magnesium glycinate in its Magnesium Complex blend, which is formulated for intracellular repletion rather than just serum correction.
Omega-3 (EPA/DHA) — EPA has demonstrated antiarrhythmic properties in both observational and interventional studies, in part by stabilizing cardiac membrane phospholipids and reducing inflammatory eicosanoid production. At clinical doses of 1–2 g EPA+DHA daily, omega-3 supplementation has been associated with reduced supraventricular ectopy in population studies (Mozaffarian & Wu, JACC 2011; PMID: 21982312). Ones includes pharmaceutical-grade Omega-3 calibrated to this range.
Adrenal Support (System Blend) — because sympathetic overdrive is central to both palpitation frequency and perceived intensity, Ones' proprietary Adrenal Support blend addresses the HPA-axis component of this picture. In women with estrogen-related autonomic dysregulation, cortisol dysregulation frequently co-exists and amplifies palpitation burden.
Ones' AI practitioner analyzes blood work and wearable data together — heart rate variability from a wearable paired with inflammatory markers from labs gives a far more precise picture than either data stream alone. Formulas are then calibrated to a 6 or 9-capsule daily plan based on what the findings actually warrant.
---
Key Takeaways
- Heart palpitations in endometriosis are mechanistically linked to systemic inflammation, estrogen-driven cardiac ion channel disruption, and magnesium depletion — not just stress or anxiety.
- The same pathways intensify during perimenopause and menopause as estrogen fluctuations become more unpredictable, and they can be acute after hysterectomy with oophorectomy due to abrupt estrogen withdrawal.
- Tracking hsCRP, homocysteine, RBC magnesium, and fasting insulin alongside thyroid markers gives the most actionable lab picture for hormone-related palpitations.
- Magnesium repletion (preferably assessed via RBC magnesium) is one of the highest-yield interventions for reducing ectopic beats in estrogen-depleted or fluctuating-estrogen states.
- Omega-3 fatty acids at clinical doses have antiarrhythmic properties independent of lipid effects, making them relevant for both cardiac rhythm stability and the systemic inflammation that underlies endometriosis.
- Persistent, frequent, or symptomatic palpitations always warrant cardiac evaluation — a personalized supplement protocol is adjunctive support, not a substitute for cardiology workup.